MORGAN HAYES MCALVIN: Open Payments
NPI 1972175578 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 56 payments from 18 companies in 2025. Trend: 2023 $1,017 · 2024 $1,478 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $151 |
| Mallinckrodt Hospital Products Inc. | 7 | $142 |
| Calliditas Therapeutics US Inc. | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Vifor Pharma, Inc. | 4 | $96 |
| Ardelyx, Inc. | 4 | $82 |
| Travere Therapeutics, Inc. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| NxStage Medical, Inc. | 1 | $54 |
| Aurinia Pharma U.S., Inc. | 2 | $46 |
Products named: JYNARQUE, TERLIVAZ, TARPEYO, FARXIGA, Veltassa, IBSRELA, Kerendia, NXSTAGE CARTRIDGE EXPRESS.
Industry payments across GA — which companies pay providers there.
